We are committed to finding a cure for WM.

Did you know?

 

Welcome to the Waldenstrom’s Macroglobulinemia Foundation of Canada (WMFC)

If you have been diagnosed with Waldenstrom’s Macroglobulinemia (WM) or care for someone who has, welcome to the WMFC family of WM patients, caregivers, friends and relatives. We are a community providing support, research and information on WM.

Sign up for our newsletter below to receive updated information.

 

Information for the newly diagnosed

**Ensure you receive all the latest news on research, events, the Torch and support by keeping your email up to date and including WMFC and IWMF as trusted senders as well as keeping your mailing address up to date.

Abstract: BeiGene Initiates Global Phase III Trial of the BTK Inhibitor BGB-3111 in Waldenström’s Macroglobulinemia

Go to website – http://pipelinereview.com/index.php/2017012563690/Small-Molecules/BeiGene-Initiates-Global-Phase-III-Trial-of-the-BTK-Inhibitor-BGB-3111-in-Waldenstroms-Macroglobulinemia.html PDF – BeiGene Initiates Global Phase III Trial of the BTK Inhibitor BGB-3111 in Waldenström’s Macroglobulinemia | Small Molecules | News Channels BeiGene Initiates Global Phase IIIRead More

Waldenström macroglobulinemia: 2017 update on diagnosis, risk stratification, and management

http://onlinelibrary.wiley.com/doi/10.1002/ajh.24557/full Get the PDF Here – Gertz-2017-Annual Clinical Updates in Hematological Malignancies Abstract Disease Overview: Waldenström macroglobulinemia (WM) is a lymphoplasmacytic lymphoma with immunoglobulin M (IgM) monoclonal protein. Clinical features includeRead More

National Comprehensive Cancer Network provides WM Guidelines

The National Comprehensive Cancer Network has provided a new Waldenstrom’s Macroglobuliemia Guidelines document. These are the guidelines that are followed by Medicare and many other insurance companies. It is aRead More

Mayo Clinic Update on Diagnosis and Treatment of WM

          This open source article was recently published in the American Journal of Hematology.  Waldenström macroglobulinemia: 2017 update on diagnosis, risk stratification, and management Authors MorieRead More

 

Subscribe to our newsletter